Involvement of hepatoma-derived growth factor in the growth inhibition of hepatocellular carcinoma cells by vitamin K2
Authors:
- 13 February 2009
- journal article
- Published by Springer Nature in Journal of Gastroenterology
- Vol. 44 (3) , 228-235
Abstract
Vitamin K2 has been reported to suppress the growth of human hepatocellular carcinoma (HCC) in vitro and hepatocarcinogenesis in hepatitis C virus (HCV)-related cirrhosis in vivo. Hepatoma-derived growth factor (HDGF) is a unique nuclear targeting growth factor that is highly expressed in HCC cells and is a possible prognostic factor for patients with HCC. We investigated the regulation of HDGF expression by vitamin K2. Three HCC-derived cell lines, HepG2, HuH-7, and SK-Hep-1, were used. Cell number was determined with the MTT assay. The expression levels of HDGF mRNA and protein were measured by the real-time reverse transcriptase-polymerase chain reaction (PCR) method and ELISA and Western blot analysis, respectively. The HDGF promoter activity was measured by a dual luciferase-reporter assay. Vitamin K2 suppressed the growth of the three HCC cell lines in a dose-dependent manner. Vitamin K2 significantly suppressed the expression of the HDGF protein and mRNA in three cell lines. By a luciferase assay, vitamin K2 significantly suppressed the promoter activity of the HDGF protein. Based on some luciferase-reporter plasmids containing truncated promoter regions, the possible responsive site of vitamin K2 seems to reside in the region −1 to −150 bp of the HDGF gene. These findings suggested that regulation of the HDGF gene expression is one of the crucial mechanisms of vitamin K2-induced cell growth suppression for HCC.Keywords
This publication has 33 references indexed in Scilit:
- Expression Level of Hepatoma-Derived Growth Factor Correlates with Tumor Recurrence of Esophageal CarcinomaAnnals of Surgical Oncology, 2007
- Synergistic growth inhibition by acyclic retinoid and vitamin K2 in human hepatocellular carcinoma cellsCancer Science, 2007
- Hepatoma-Derived Growth Factor Is a Novel Prognostic Factor for Patients with Pancreatic CancerClinical Cancer Research, 2006
- Hepatoma-Derived Growth Factor Is a Novel Prognostic Factor for Hepatocellular CarcinomaAnnals of Surgical Oncology, 2006
- Diverse cellular transformation capability of overexpressed genes in human hepatocellular carcinomaBiochemical and Biophysical Research Communications, 2004
- Expression of hepatoma‐derived growth factor in hepatocellular carcinomaCancer, 2003
- Hepatoma-derived growth factor is highly expressed in developing liver and promotes fetal hepatocyte proliferationHepatology, 2002
- Hepatoma-derived growth factor is highly expressed in developing liver and promotes fetal hepatocyte proliferationHepatology, 2002
- Hepatoma-derived growth factor stimulates smooth muscle cell growth and is expressed in vascular developmentJournal of Clinical Investigation, 2000
- An endothelial growth factor involved in rat renal development.Journal of Clinical Investigation, 1998